The aim of this study is to describe the treatment pattern and patient characteristics in real life setting in patients with Bipolar disorder treated with Seroquel XR and/or Seroquel IR in Sweden.
An epidemiological registry study to evaluate clinical practice treatment in patients with Bipolar Disorder treated with quetiapine XR and/or quetiapine IR
Study Type
OBSERVATIONAL
Enrollment
16,000
Description of detailed clinical treatment in terms of duration of treatment, doses, drug switches, and add-on therapy, in patients with BD and on treatment with quetiapine XR and/or quetiapine IR before, at and after the index date.
Time frame: 1st of January 2009 to 31st of December 2010.
Description of co-morbidity, demographics, sick leave, early retirement and socioeconomic factors in patients with BD and on treatment with quetiapine XR and/or quetiapine IR before and at the index date.
Time frame: 1st of January 2009 to 31st of December 2010.
Description of the detailed clinical treatment in terms of duration of treatment, doses, drug switches, and add-on therapy, in patients with BD, including all drug treatment after the index date
Time frame: 1st of January 2009 to 31st of December 2010.
Description of co-morbidity, demographics, sick leave, early retirement and socioeconomic factors in patients with BD, including all drug treatment before and at the index date
Time frame: 1st of January 2009 to 31st of December 2010.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.